Search
Dogwood Therapeutics Inc
DWTXAdd to Watchlist
1.510USD
0.0000.00%
Close 09-23 16:00（ET）
50.78MMarket Cap
LossP/E TTM
Dogwood Therapeutics Inc (DWTX) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Dogwood Therapeutics Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
13.500USD+794.04%
DWTX Analyst Recommendation Trends
In the current month, DWTX has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DWTX average Analyst price target in the last month is 13.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
DWTX Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, DWTX EPS is projected to reach -0.155 in FY2026Q3, following reported EPS of -0.338 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.16
-0.26
-0.14
-0.15
-0.16
Actual
-0.26
-0.15
-0.34
--
--
Surprise
+77.72%
+42.08%
-141.30%
--
--
FAQs
What is Dogwood Therapeutics Inc's price target?
Analysts forecast that Dogwood Therapeutics Inc's price target is USD 13.50, with the highest forecast at USD 15.00 and the lowest forecast at USD 12.00.
How have Dogwood Therapeutics IncDWTX's recent earnings per share performed?
The market expectation was USD -0.34, while Dogwood Therapeutics IncDWTX's earnings per share (EPS) for the previous quarter was USD -0.15. EPS for the next quarter is expected at USD -0.15.
What is the analyst rating for Dogwood Therapeutics Inc?
Based on the ratings of Dogwood Therapeutics Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.